– $INO +262% (FDA grants accelerated approval to VOCERYQ to reduce surgery frequency in adults with recurrent respiratory papillomatosis) – $PERI +31% (agrees to be acquired by Affle for $11.70 a share in cash, valuing the deal at about $420M) – $IDXX +7.8% (Q3 beat and FY revenue and EPS outlooks were raised, outweighing a …
Read in context ›Gold Fields Stock (GFI)
Track Gold Fields stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
GFI
Gold Fields
basicmaterials
At close
$35.78
â–¼ -1.78 (-4.74%)
Nov 12, 4:00 PM ET
Pre-market
$35.63
â–¼ -0.15 (-0.42%)
Nov 13, 5:34 AM ET
Market Cap
$34.09B
P/E Ratio
7.4x
1Y Return
-13.16%
EPS (TTM)
$4.93
Read the latest TheStreet Pro articles mentioning Gold Fields, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning GFI yet.
Daily Diary Mentions
3 mentionsBABA Up, PGEN Down: Upside, Downside Movers in the Morning Upgrades, Downgrades and New Research Coverage Upgrades: ArcelorMittal ($MT) upgraded to Overweight from Neutral at JPMorgan Array Technologies ($ARRY) upgraded to Outperform from Neutral at Mizuho, Target: $5 Bank of America ($BAC) upgraded to Outperform from Neutral at Baird, Target: $62 BorgWarner ($BWA) upgraded to Buy from Neutral at BofA, Target: $85 Brighthouse Financial ($BHF) upgraded to Neutral from Underweight at …
Read in context ›Upside, Downside Movers in the Morning Upside – $KOD +60% (pivotal Phase 3 DAYBREAK wet-AMD trial met its primary noninferiority endpoints, with most patients reaching a 24-week dosing interval) – $ARAY +39% (agrees to explore integrating Samsung NeuroLogica volumetric imaging technology with the CyberKnife platform) – $MEDS +28% (launches a GLP-1 care app offering telehealth consultations and access to branded medications) …
Read in context ›